Sharepoint Solutions
PRODUCTS
-
![Sanitary Flanges]( "Sanitary Flanges")
Qosina carries a wide assortment of sanitary flange fittings available in over 80 options. Our flanges are ASME-BPE compliant and include regulatory documentation, CAD drawings and validation test data.
-
![Rohde & Schwarz - ATS1500C 2]( "Antenna Test Chamber For Automotive Radar: ATS1500C")
The R&S® ATS1500C antenna test chamber is a compact antenna test range (CATR), consisting of a gold-plated parabolic reflector and a two-axis positioner for 3D movements of the DUT.
-
![iStock-1214112153-computer-lab-microscope]( "Analytical Development")
AGC Biologics develops analytical methods for product release, product characterization and process development support. Robust and validated release methods, including bioassays, are developed to ensure the identity, safety, purity and potency of your product.
Our in-house bioassay group specializes in development and validation of cell-based assays. This speeds results and eliminates the need for third party interactions.
-
![Aseptic-filling]( "Aseptic Filling Systems For Biopharmaceutical Manufacturing")
AST aseptic filling products address the unique processing requirements of biologics manufacturing to gently care for biologic products during the fill-finish process. Their highly accurate peristaltic dosing system uses single-use pharmaceutical grade tubing that has been optimized to keep shear stress to an absolute minimum. When exiting the fluid path through the filling needle, the motion control system maintains the fill needle within the container and slowly rises as the product is being dispensed to minimize splashing and foaming that could introduce stress to the product. Temperature controlled filling is also possible with the ASEPTiCell® and GENiSYS® systems. AST has experience dosing products at temperatures as low as 3°C.
-
![QPD1028_PDP]( "GaN On SiC RF Transistor: QPD1028")
The QPD1028 is a 750W discrete GaN on SiC HEMT that operates from 1.2 to 1.4 GHz, providing typically 59dBm of saturated output power with 18dB of large-signal gain and 70% of drain efficiency.
WHITE PAPERS AND CASE STUDIES
-
![eSource Is Here: What To Do Today To Ensure Success Tomorrow]( "A Site Network’s Experience With eSource Before And During COVID")
A Site Network’s Experience With eSource Before And During COVIDDiscover how the world's leading vaccine network adopted eSource during COVID-19 despite many obstacles that got in their way.
-
![FDA Approved]( "The Future Of The FDA: Operating In An “Electronic World”")
The Future Of The FDA: Operating In An “Electronic World”Explore the FDA's e-transformation that promises to usher in a new era of electronic interactions between the agency and its constituents.
-
![GettyImages-673805662-cell-processing-lab-development]( "Proactively Addressing Access And Reimbursement Challenges For ALS Therapeutics")
Proactively Addressing Access And Reimbursement Challenges For ALS TherapeuticsIn this white paper, learn why ensuring patient access to new ALS therapies requires more than regulatory approval of such therapies.
-
![GettyImages-1146473276-team-collaboration-partnership-discussion]( "Why Early Market Access Planning Is Crucial In CGT Commercial Strategy")
Why Early Market Access Planning Is Crucial In CGT Commercial StrategyBringing cell and gene therapies (CGTs) to market and ensuring patient access is a complex process. Discover how developing a market access strategy and partnering with experts can help.
-
![coronavirus covid-GettyImages-1220020527]( "Expert Consulting And MRCT Strategy Rescues Oncology Program")
Expert Consulting And MRCT Strategy Rescues Oncology ProgramUncover how this strategic approach yielded significant outcomes, including uncovering missing data through IB review, streamlining dosing timelines, and achieving successful recruitment milestones.
-
![GettyImages-1287090754 Update written on wooden blocks]( "NuGenesis 9.3 – What’s New")
NuGenesis 9.3 – What’s NewExplore the latest features of a user-centric lab management system that comprises data, workflow, and sample management capabilities to support the entire product lifecycle.
-
![GettyImages-1219958640 global health]( "The State Of Global Clinical Trial Disclosure")
The State Of Global Clinical Trial DisclosureSee what industry organizations are saying about trial transparency, regulations by region, what penalties are on the books, and whether they are enforced.
-
![Gender equality womens rights GettyImages-1209252233]( "Women-Centric Approach To Clinical Trials")
Women-Centric Approach To Clinical TrialsWomen are demanding more power, information, and control when it comes to their health. Learn how women now have a stronger voice when it comes to clinical research for treatments that impact their care.
-
![iStock-1211951067-distribution-global-network]( "To Future-Proof The Pharma Supply Chain, Digitize")
To Future-Proof The Pharma Supply Chain, DigitizeThe demand for pharma products is growing — can the industry keep up? Explore three ways digitization can help pharmaceutical companies bridge the widening gap between supply and demand.
-
![Rohde - scenario example]( "Testing For Coexistence In Crowded And Contested RF Environments")
Testing For Coexistence In Crowded And Contested RF EnvironmentsIn this paper, we review some of the key research, development, test and evaluation (RDT&E) challenges that arise when developing and deploying systems that need to operate in congested and/or contested RF environments.
-
![AST filling syringes]( "Considerations For Pre-Filled Syringes For 503(b) Compounding Facilities")
Considerations For Pre-Filled Syringes For 503(b) Compounding FacilitiesIndustry experts weigh in on how to help 503(b) compounding facilities bring acute care drugs to market more quickly, provide a safer drug administration process, and minimize health care and hospital costs.
-
![GettyImages-946433872-assay-development-96well]( "Method Optimization: Assay Development Following Compendial Methods")
Method Optimization: Assay Development Following Compendial MethodsThere was a short time frame of only 7 weeks to complete assay optimization and conduct pre-validation studies within the confines of USP<621>.
NEWS
-
Biden-Harris Administration Announces $330M WIFIA Loan To Reduce Air Emissions From Wastewater Treatment Plants In Missouri10/10/2023
Today, the U.S. Environmental Protection Agency (EPA) announced a Water Infrastructure Finance and Innovation Act (WIFIA) loan totaling $330 million to the Metropolitan St. Louis Sewer District (MSD Project Clear) in Missouri
-
Administration Awards $1.3B In Loans, Grants For Water Infrastructure Projects4/18/2023
On April 10, the Healey-Driscoll administration announced that 185 projects across the Commonwealth are eligible to receive approximately $1.3B in low-interest-rate loans and grants to fund construction, planning and asset management projects designed to improve water quality, upgrade or replace aging drinking water and wastewater infrastructure, and cut treatment plant energy use and costs.
-
Biden-Harris Administration Announces $74M WIFIA Loan To Pajaro Valley Water Management Agency In Santa Cruz2/27/2024
Today, the U.S. Environmental Protection Agency (EPA) announced two Water Infrastructure Finance and Innovation Act (WIFIA) loans totaling $74M to the Pajaro Valley Water Management Agency in Santa Cruz County, California.
-
EGLE Announces $45M In MI Clean Water Grants To Help Michigan Communities Upgrade Water Infrastructure, Protect Health And The Environment9/8/2023
Wastewater system upgrades in Upper Peninsula communities, lead service line replacements in Melvindale and improvements to Mt. Pleasant’s wastewater plant are among $45M in Michigan Department of Environment, Great Lakes, and Energy (EGLE) grants recently awarded to Michigan communities.
-
DEQ Awards Nearly $51M To 14 Drinking Water And Wastewater Systems Across Idaho4/5/2023
The Idaho Department of Environmental Quality (DEQ) today announced the award of $50,550,110 in construction grants to 14 drinking water and wastewater systems.